Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Agarwal

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Pharmaceutics|April 27, 2024
Exploring the Impact of Hepatic Impairment on Pralsetinib PharmacokineticsKit Wun Kathy Cheung, Yang Tang, Doreen Anders, et al.
BMC Geriatrics|October 17, 2020
Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort studyRajkumar Chinnadurai, Onesi Ogedengbe, Priya Agarwal, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2016
A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activitiesDan Lu, Tong Lu, Mark Stroh, et al.
Global Mental Health (Cambridge, England)|September 25, 2025
Mental health of female Venezuelan migrant caregivers in Colombia: A multi-study, mixed-methods analysisMaría Pineros-Leano, Priya Agarwal-Harding, Brielle Ruscitti, et al.
Epilepsy & Behavior : E&B|January 22, 2019
Effect of sleep quality on memory, executive function, and language performance in patients with refractory focal epilepsy and controlled epilepsy versus healthy controls - A prospective studyKamalesh Chakravarty, Garima Shukla, Shivani Poornima, et al.
Clinical and Translational Science|October 5, 2022
Mitigating ipatasertib-induced glucose increase through dose and meal timing modificationsDhruvitkumar S Sutaria, Priya Agarwal, Kuan-Chieh Huang, et al.
Mabs|December 20, 2019
Clinical pharmacology of vc-MMAE antibody-drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studiesChunze Li, Cindy Zhang, Zao Li, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2020
Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphomaColby S Shemesh, Priya Agarwal, Tong Lu, et al.
Clinical and Translational Science|October 21, 2023
Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non-Asian patients with previously untreated diffuse large B-cell lymphoma in POLARIXMichael Z Liao, Rong Deng, Leonid Gibiansky, et al.
Leukemia & Lymphoma|July 25, 2020
Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphomaTong Lu, Leonid Gibiansky, Xiaobin Li, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Pharmaceutics|April 27, 2024
Exploring the Impact of Hepatic Impairment on Pralsetinib PharmacokineticsKit Wun Kathy Cheung, Yang Tang, Doreen Anders, et al.
BMC Geriatrics|October 17, 2020
Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort studyRajkumar Chinnadurai, Onesi Ogedengbe, Priya Agarwal, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2016
A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activitiesDan Lu, Tong Lu, Mark Stroh, et al.
Global Mental Health (Cambridge, England)|September 25, 2025
Mental health of female Venezuelan migrant caregivers in Colombia: A multi-study, mixed-methods analysisMaría Pineros-Leano, Priya Agarwal-Harding, Brielle Ruscitti, et al.
Epilepsy & Behavior : E&B|January 22, 2019
Effect of sleep quality on memory, executive function, and language performance in patients with refractory focal epilepsy and controlled epilepsy versus healthy controls - A prospective studyKamalesh Chakravarty, Garima Shukla, Shivani Poornima, et al.
Clinical and Translational Science|October 5, 2022
Mitigating ipatasertib-induced glucose increase through dose and meal timing modificationsDhruvitkumar S Sutaria, Priya Agarwal, Kuan-Chieh Huang, et al.
Mabs|December 20, 2019
Clinical pharmacology of vc-MMAE antibody-drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studiesChunze Li, Cindy Zhang, Zao Li, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2020
Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphomaColby S Shemesh, Priya Agarwal, Tong Lu, et al.
Clinical and Translational Science|October 21, 2023
Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non-Asian patients with previously untreated diffuse large B-cell lymphoma in POLARIXMichael Z Liao, Rong Deng, Leonid Gibiansky, et al.
Leukemia & Lymphoma|July 25, 2020
Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphomaTong Lu, Leonid Gibiansky, Xiaobin Li, et al.
Pageof 7